Results 1 to 10 of about 4,466,693 (321)

Arsenic causing gallbladder cancer disease in Bihar

open access: yesScientific Reports, 2023
In recent times Gallbladder cancer (GBC) incidences increased many folds in India and are being reported from arsenic hotspots identified in Bihar. The study aims to establish association between arsenic exposure and gallbladder carcinogenesis.
Arun Kumar   +21 more
doaj   +2 more sources

Gallbladder cancer: current and future treatment options

open access: yesFrontiers in Pharmacology, 2023
Surgery remains the preferred treatment option for early-stage gallbladder cancer (GBC). According to the anatomical position of the primary tumor, accurate preoperative stage and strict control of surgical indications, appropriate surgical strategies ...
Yanzhao Zhou   +14 more
doaj   +2 more sources

XRCC1 Is a Promising Predictive Biomarker and Facilitates Chemo-Resistance in Gallbladder Cancer

open access: yesFrontiers in Molecular Biosciences, 2020
Gallbladder cancer is a relatively uncommon human malignant tumor with an extremely poor prognosis. Currently, no biomarkers can accurately diagnose gallbladder cancer and predict patients’ prognosis.
Zhengchun Wu   +7 more
doaj   +2 more sources

Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy

open access: yesMolecular Cancer, 2019
Background Gallbladder cancer is the most common biliary tract malignancy and not sensitive to chemotherapy. Autophagy is an important factor prolonging the survival of cancer cells under chemotherapeutic stress.
Qiang Cai   +7 more
doaj   +2 more sources

Epidemiology of gallbladder cancer

open access: yesClinical and Experimental Hepatology, 2019
According to GLOBOCAN 2018 data, gallbladder cancer (GBC) accounts for 1.2% of all global cancer diagnoses, but 1.7% of all cancer deaths. Only 1 in 5 GBC cases in the United States is diagnosed at an early stage, and median survival for advanced stage cancer is no more than about a year.
Tagore Sunkara   +3 more
openaire   +4 more sources

Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate

open access: yesNature Communications, 2020
Gallbladder cancer incidence shows characteristic geographic patterns. Here the authors perform a genomic analysis of gallbladder cancers in patients from countries with high incidence (South Korea, India and Chile) and identify ELF3 and other ...
Akhilesh Pandey   +39 more
doaj   +2 more sources

Aspartate beta-hydroxylase is a prognostic factor in gallbladder cancer with the function of promoting tumorigenesis and chemoresistance [PDF]

open access: yesFrontiers in Endocrinology
AimsGallbladder cancer is characterized by a dismal prognosis, with a limited number of biological markers currently identified for the carcinogenesis, progression and prognosis of gallbladder cancers (GBCs).
Luo Yuan   +4 more
doaj   +2 more sources

Global trends in gallbladder cancer survival: A 30-year analysis of cancer registry data [PDF]

open access: yesHeliyon
Background: Gallbladder cancer has historically been characterized with a poor prognosis. This study aims to describe the global patterns and temporal trends in gallbladder cancer survival using data from cancer registries.
Yu-Xuan Xiao   +8 more
doaj   +2 more sources

Risk factors for gallbladder cancer

open access: yesJournal of Education, Health and Sport, 2020
Introduction and purpose:                Gallbladder cancer is the most common neoplasm of the bile duct. Early GBC is usually asymptomatic, but is prone to early metastases. This means that most GBC cases are diagnosed very late, and this contributes to the poor prognosis of this disease.
Magdalena Suchodolska   +4 more
openaire   +5 more sources

Incidental gallbladder cancer

open access: bronzeThe American Journal of Gastroenterology, 2001
Vinay K. Kapoor
openalex   +4 more sources

Home - About - Disclaimer - Privacy